FEATURED ARTICLES
Unicycive Therapeutics' Framework For Speedier Clinical Trials
Unicycive Therapeutics Vice President of R&D Guru Reddy, Ph.D., shares how his small team moved swiftly through a recent early phase trial.
-
AI Can Help Design Better Trials, But It Still Can't Tell You Whether Patients Will Join Them
AI is changing the way clinical trial trials are discussed, planned, and designed. But even with an improved protocol, are AI-enhanced trials driving better enrollment?
-
Where Are We With Clinical Trial Tokenization?
In January 2024, I interviewed Tom Dougherty about a topic many clinical research professionals had heard mentioned but few could confidently explain: tokenization. I wanted to get caught up on any progress that has been made, so I completed this Q&A with Dougherty, who is Real-World Data Strategy Director, CMR - Clinical Data Science & Evidence at Novo Nordisk.
-
To Prevent Parkinson's Disease, We Need New Biomarkers
Parkinson's disease research has shifted toward prevention and prodromal intervention but success with disease-modifying and preventive therapies depends on validated PD-specific biomarkers. AC Immune Cofounder and CEO Andrea Pfeifer explains.